Abstract.
Recent research into the genetic basis and the molecular disease mechanisms of Charcot-Marie-Tooth disease (CMT), also called hereditary motor and sensory neuropathies, has highlighted phosphoinositides, membrane-tethered phosphorylated metabolites of phosphatidylinositol, as key regulatory molecules in peripheral nerves in health and disease. Enzymes that dephosphorylate the endosomal phosphoinositides phosphatidylinositol-3-phosphate and/or phosphatidylinositol-3,5-biphosphate, and proteins with binding domains for these phosphoinositides, are mutated in subtypes of CMT. A hypothetical picture emerges suggesting that the precise regulation of phosphoinositide levels within neural cells, a process in turn critical for the correct dynamics of proteins binding to phosphoinositides, is a crucial bottleneck for the accurate function of myelinated peripheral nerves in both neurons and Schwann cells. The underlying molecular and cellular mechanisms are largely unknown. Some hypotheses are discussed in this essay.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 19 August 2007; received after revision 3 October 2007; accepted 9 October 2007
Rights and permissions
About this article
Cite this article
Suter, U. Phosphoinositides and Charcot-Marie-Tooth disease: New keys to old questions. Cell. Mol. Life Sci. 64, 3261–3265 (2007). https://doi.org/10.1007/s00018-007-7381-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-007-7381-7